Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs aimed toward increasing the horizons of cytokine-based immunotherapy, specifically for cancers where cure selections remain limited. Make use of the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Take a https://financefeeds.com/naga-revenue-declines-post-merger-but-ebitda-margin-improves/